{"transactions":[{"id":701577,"issuer":{"id":4644,"kind":"organization","name":"Freenome, Inc.","symbol":"FRNM"},"owners":[{"id":28053,"kind":"person","name":"Waksal Harlan","position":1,"cik":"0001449008","reported_name":"Waksal Harlan","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director"}}],"security":"Class B Ordinary Shares","published_at":"2026-07-29T21:19:31.000Z","date":"2026-07-20","kind":"exercise","planned":false,"acquired":false,"shares":30000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Pursuant to the Business Combination Agreement, dated December 5, 2025 and amended on July 20, 2026 by and among the Issuer, Freenome Holdings, Inc. (\"Old Freenome\"), StarNet Merger Sub I, Corp., a wholly-owned subsidiary of the Issuer and StarNet Merger Sub II, LLC, a wholly owned subsidiary of the Issuer (the \"BCA\"), on July 20, 2026 (the \"Closing Date\"), the Issuer consummated its business combination with Old Freenome (the \"Business Combination\"). In connection with the closing of Business Combination, the Issuer's Class B Ordinary Shares converted into Class A Ordinary Shares on a one-to-one basis and subsequently converted into shares of Common Stock on a one-to-one basis."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Business Combination Agreement, dated December 5, 2025 and amended on July 20, 2026 by and among the Issuer, Freenome Holdings, Inc. (\"Old Freenome\"), StarNet Merger Sub I, Corp., a wholly-owned subsidiary of the Issuer and StarNet Merger Sub II, LLC, a wholly owned subsidiary of the Issuer (the \"BCA\"), on July 20, 2026 (the \"Closing Date\"), the Issuer consummated its business combination with Old Freenome (the \"Business Combination\"). In connection with the closing of Business Combination, the Issuer's Class B Ordinary Shares converted into Class A Ordinary Shares on a one-to-one basis and subsequently converted into shares of Common Stock on a one-to-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the Business Combination Agreement, dated December 5, 2025 and amended on July 20, 2026 by and among the Issuer, Freenome Holdings, Inc. (\"Old Freenome\"), StarNet Merger Sub I, Corp., a wholly-owned subsidiary of the Issuer and StarNet Merger Sub II, LLC, a wholly owned subsidiary of the Issuer (the \"BCA\"), on July 20, 2026 (the \"Closing Date\"), the Issuer consummated its business combination with Old Freenome (the \"Business Combination\"). In connection with the closing of Business Combination, the Issuer's Class B Ordinary Shares converted into Class A Ordinary Shares on a one-to-one basis and subsequently converted into shares of Common Stock on a one-to-one basis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Pursuant to the Business Combination Agreement, dated December 5, 2025 and amended on July 20, 2026 by and among the Issuer, Freenome Holdings, Inc. (\"Old Freenome\"), StarNet Merger Sub I, Corp., a wholly-owned subsidiary of the Issuer and StarNet Merger Sub II, LLC, a wholly owned subsidiary of the Issuer (the \"BCA\"), on July 20, 2026 (the \"Closing Date\"), the Issuer consummated its business combination with Old Freenome (the \"Business Combination\"). In connection with the closing of Business Combination, the Issuer's Class B Ordinary Shares converted into Class A Ordinary Shares on a one-to-one basis and subsequently converted into shares of Common Stock on a one-to-one basis."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001449008-26-000004","document":"form4-07292026_090728.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2017526/000144900826000004/form4-07292026_090728.xml","form_type":"4"}},{"id":701576,"issuer":{"id":4644,"kind":"organization","name":"Freenome, Inc.","symbol":"FRNM"},"owners":[{"id":28053,"kind":"person","name":"Waksal Harlan","position":1,"cik":"0001449008","reported_name":"Waksal Harlan","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director"}}],"security":"Common Stock","published_at":"2026-07-29T21:19:31.000Z","date":"2026-07-20","kind":"exercise","planned":false,"acquired":true,"shares":30000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Business Combination Agreement, dated December 5, 2025 and amended on July 20, 2026 by and among the Issuer, Freenome Holdings, Inc. (\"Old Freenome\"), StarNet Merger Sub I, Corp., a wholly-owned subsidiary of the Issuer and StarNet Merger Sub II, LLC, a wholly owned subsidiary of the Issuer (the \"BCA\"), on July 20, 2026 (the \"Closing Date\"), the Issuer consummated its business combination with Old Freenome (the \"Business Combination\"). In connection with the closing of Business Combination, the Issuer's Class B Ordinary Shares converted into Class A Ordinary Shares on a one-to-one basis and subsequently converted into shares of Common Stock on a one-to-one basis."}],"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001449008-26-000004","document":"form4-07292026_090728.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2017526/000144900826000004/form4-07292026_090728.xml","form_type":"4"}},{"id":1335438,"issuer":{"id":46837,"kind":"organization","name":"Lyra Therapeutics, Inc.","symbol":"LYRA"},"owners":[{"id":28053,"kind":"person","name":"Waksal Harlan","position":1,"cik":"0001449008","reported_name":"Waksal Harlan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chair"}}],"security":"Performance-based Restricted Stock Units","published_at":"2024-12-11T18:39:09.000Z","date":"2024-12-09","kind":"grant","planned":false,"acquired":false,"shares":128333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Performance-based Restricted Stock unit (\"PSU\") represented a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On March 21, 2024, the Reporting Person was granted a PSU for an aggregate of up to 385,000 shares of common stock under the Issuer's 2020 Incentive Award Plan (the \"Agreement\"). Under the terms of the Agreement, the underlying PSUs will become earned upon certain milestone events.  On December 9, 2024, the Issuer determined that Milestone 1 of the PSU was achieved, resulting in 128,333 PSUs being earned.  The earned PSUs will vest on January 31, 2028.  The PSUs have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On March 21, 2024, the Reporting Person was granted a PSU for an aggregate of up to 385,000 shares of common stock under the Issuer's 2020 Incentive Award Plan (the \"Agreement\"). Under the terms of the Agreement, the underlying PSUs will become earned upon certain milestone events.  On December 9, 2024, the Issuer determined that Milestone 1 of the PSU was achieved, resulting in 128,333 PSUs being earned.  The earned PSUs will vest on January 31, 2028.  The PSUs have no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":128333},"source":{"system":"sec-edgar","filing":"0000950170-24-135515","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1449008/000095017024135515/ownership.xml","form_type":"4"}},{"id":1565894,"issuer":{"id":46837,"kind":"organization","name":"Lyra Therapeutics, Inc.","symbol":"LYRA"},"owners":[{"id":28053,"kind":"person","name":"Waksal Harlan","position":1,"cik":"0001449008","reported_name":"Waksal Harlan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chair"}}],"security":"Common Stock","published_at":"2024-03-20T19:21:52.000Z","date":"2024-03-18","kind":"grant","planned":false,"acquired":true,"shares":275000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of restricted stock units (\"RSUs\").  Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on January 31, 2025."}],"balance_after":536966,"source":{"system":"sec-edgar","filing":"0000950170-24-034350","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1449008/000095017024034350/ownership.xml","form_type":"4"}},{"id":1743862,"issuer":{"id":46837,"kind":"organization","name":"Lyra Therapeutics, Inc.","symbol":"LYRA"},"owners":[{"id":28053,"kind":"person","name":"Waksal Harlan","position":1,"cik":"0001449008","reported_name":"Waksal Harlan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chair"}}],"security":"Common Stock","published_at":"2023-11-13T17:29:27.000Z","date":"2023-11-10","kind":"purchase","planned":false,"acquired":true,"shares":25000,"price":2.9638,"value":74095.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at per share prices ranging from $2.83 to $3.00. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":261966,"source":{"system":"sec-edgar","filing":"0000950170-23-063137","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1449008/000095017023063137/ownership.xml","form_type":"4"}},{"id":2035871,"issuer":{"id":46837,"kind":"organization","name":"Lyra Therapeutics, Inc.","symbol":"LYRA"},"owners":[{"id":28053,"kind":"person","name":"Waksal Harlan","position":1,"cik":"0001449008","reported_name":"Waksal Harlan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chair"}}],"security":"Stock Option","published_at":"2023-02-02T17:19:30.000Z","date":"2023-01-31","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests and becomes exercisable in 48 equal monthly installments occurring on the completion of each successive month of the Reporting Person's service to the Issuer following January 31, 2023."}],"balance_after":200000,"derivative":{"exercise_price":2.85,"expiration_date":"2033-01-30","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0000899243-23-003522","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1449008/000089924323003522/doc4.xml","form_type":"4"}},{"id":2225303,"issuer":{"id":46837,"kind":"organization","name":"Lyra Therapeutics, Inc.","symbol":"LYRA"},"owners":[{"id":28053,"kind":"person","name":"Waksal Harlan","position":1,"cik":"0001449008","reported_name":"Waksal Harlan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chair"}}],"security":"Stock Option","published_at":"2022-06-21T16:06:00.000Z","date":"2022-06-16","kind":"grant","acquired":true,"shares":953002,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On June 16, 2022, the Reporting Person was granted an option to purchase 953,002 shares of common stock. The option vests and becomes exercisable as to 317,667 shares underlying the option when the Issuer's market capitalization reaches $250,000,000; (ii) 317,667 shares underlying the option when the Issuer's market capitalization reaches $350,000,000; and (iii) 317,668 shares underlying the option when the Issuer's market capitalization reaches $500,000,000, all subject to the Reporting Person's continued service to the Issuer through each such date."}],"balance_after":953002,"derivative":{"exercise_price":5.09,"expiration_date":"2032-06-15","underlying":"Common Stock","underlying_shares":953002},"source":{"system":"sec-edgar","filing":"0000899243-22-023336","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1449008/000089924322023336/doc4.xml","form_type":"4"}},{"id":2297673,"issuer":{"id":46837,"kind":"organization","name":"Lyra Therapeutics, Inc.","symbol":"LYRA"},"owners":[{"id":28053,"kind":"person","name":"Waksal Harlan","position":1,"cik":"0001449008","reported_name":"Waksal Harlan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chair"}}],"security":"Common Stock","published_at":"2022-04-13T19:16:44.000Z","date":"2022-04-12","kind":"purchase","acquired":true,"shares":236966,"price":4.22,"value":999996.52,"ownership":{"direct":true},"balance_after":236966,"source":{"system":"sec-edgar","filing":"0000899243-22-014737","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1449008/000089924322014737/doc4.xml","form_type":"4"}},{"id":2385208,"issuer":{"id":46837,"kind":"organization","name":"Lyra Therapeutics, Inc.","symbol":"LYRA"},"owners":[{"id":28053,"kind":"person","name":"Waksal Harlan","position":1,"cik":"0001449008","reported_name":"Waksal Harlan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chair"}}],"security":"Stock Option","published_at":"2022-02-18T17:09:45.000Z","date":"2022-02-16","kind":"grant","acquired":true,"shares":520000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On February 16, 2022, the Reporting Person was granted an option to purchase 520,000 shares of common stock. The option vests and becomes exercisable as to 173,333 shares underlying the option when the Issuer's market capitalization reaches $250,000,000; (ii) 173,333 shares underlying the option when the Issuer's market capitalization reaches $350,000,000; and (iii) 173,334 shares underlying the option when the Issuer's market capitalization reaches $500,000,000, all subject to the Reporting Person's continued service to the Issuer through each such date."}],"balance_after":520000,"derivative":{"exercise_price":4.21,"expiration_date":"2032-02-15","underlying":"Common Stock","underlying_shares":520000},"source":{"system":"sec-edgar","filing":"0000899243-22-007038","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1449008/000089924322007038/doc4.xml","form_type":"4"}},{"id":2519531,"issuer":{"id":133686,"kind":"organization","name":"Kadmon Holdings, Inc.","symbol":"KDMN"},"owners":[{"id":28053,"kind":"person","name":"Waksal Harlan","position":1,"cik":"0001449008","reported_name":"Waksal Harlan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Equity Appreciation Rights Unit","published_at":"2021-11-09T17:42:11.000Z","date":"2021-11-09","kind":"disposition_to_issuer","acquired":true,"shares":750,"price":3.5,"value":2625.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the payment per share of Common Stock received in exchange for the cancellation of each Option, SAR and EAR."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"In connection with the Merger, all unvested stock options (\"Options\"), stock appreciation rights (\"SARs\") and equity appreciation rights (\"EARs\") were accelerated to full vesting and cancelled in exchange for a payment equal to $9.50 with respect to each share of Common Stock subject to such Option, SAR and EAR award."}],"balance_after":0,"derivative":{"exercise_price":6,"expiration_date":"2024-12-31","underlying":"Common Stock, par value $0.001","underlying_shares":750},"source":{"system":"sec-edgar","filing":"0001104659-21-136412","document":"tm2131118-11_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1449008/000110465921136412/tm2131118-11_4seq1.xml","form_type":"4"}},{"id":2519530,"issuer":{"id":133686,"kind":"organization","name":"Kadmon Holdings, Inc.","symbol":"KDMN"},"owners":[{"id":28053,"kind":"person","name":"Waksal Harlan","position":1,"cik":"0001449008","reported_name":"Waksal Harlan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Stock Option (right to buy)","published_at":"2021-11-09T17:42:11.000Z","date":"2021-11-09","kind":"disposition_to_issuer","acquired":true,"shares":2000000,"price":5.54,"value":11080000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the payment per share of Common Stock received in exchange for the cancellation of each Option, SAR and EAR."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"In connection with the Merger, all unvested stock options (\"Options\"), stock appreciation rights (\"SARs\") and equity appreciation rights (\"EARs\") were accelerated to full vesting and cancelled in exchange for a payment equal to $9.50 with respect to each share of Common Stock subject to such Option, SAR and EAR award."}],"balance_after":0,"derivative":{"exercise_price":3.96,"expiration_date":"2031-01-08","underlying":"Common Stock, par value $0.001","underlying_shares":2000000},"source":{"system":"sec-edgar","filing":"0001104659-21-136412","document":"tm2131118-11_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1449008/000110465921136412/tm2131118-11_4seq1.xml","form_type":"4"}},{"id":2519529,"issuer":{"id":133686,"kind":"organization","name":"Kadmon Holdings, Inc.","symbol":"KDMN"},"owners":[{"id":28053,"kind":"person","name":"Waksal Harlan","position":1,"cik":"0001449008","reported_name":"Waksal Harlan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Stock Option (right to buy)","published_at":"2021-11-09T17:42:11.000Z","date":"2021-11-09","kind":"disposition_to_issuer","acquired":true,"shares":1350000,"price":5.35,"value":7222500.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the payment per share of Common Stock received in exchange for the cancellation of each Option, SAR and EAR."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"In connection with the Merger, all unvested stock options (\"Options\"), stock appreciation rights (\"SARs\") and equity appreciation rights (\"EARs\") were accelerated to full vesting and cancelled in exchange for a payment equal to $9.50 with respect to each share of Common Stock subject to such Option, SAR and EAR award."}],"balance_after":0,"derivative":{"exercise_price":4.15,"expiration_date":"2029-11-19","underlying":"Common Stock, par value $0.001","underlying_shares":1350000},"source":{"system":"sec-edgar","filing":"0001104659-21-136412","document":"tm2131118-11_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1449008/000110465921136412/tm2131118-11_4seq1.xml","form_type":"4"}},{"id":2519528,"issuer":{"id":133686,"kind":"organization","name":"Kadmon Holdings, Inc.","symbol":"KDMN"},"owners":[{"id":28053,"kind":"person","name":"Waksal Harlan","position":1,"cik":"0001449008","reported_name":"Waksal Harlan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Performance Stock Option(right to buy)","published_at":"2021-11-09T17:42:11.000Z","date":"2021-11-09","kind":"disposition_to_issuer","acquired":true,"shares":982500,"price":5.44,"value":5344800.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the payment per share of Common Stock received in exchange for the cancellation of each Option, SAR and EAR."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"In connection with the Merger, all unvested stock options (\"Options\"), stock appreciation rights (\"SARs\") and equity appreciation rights (\"EARs\") were accelerated to full vesting and cancelled in exchange for a payment equal to $9.50 with respect to each share of Common Stock subject to such Option, SAR and EAR award."}],"balance_after":0,"derivative":{"exercise_price":4.06,"expiration_date":"2028-04-03","underlying":"Common Stock, par value $0.001","underlying_shares":982500},"source":{"system":"sec-edgar","filing":"0001104659-21-136412","document":"tm2131118-11_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1449008/000110465921136412/tm2131118-11_4seq1.xml","form_type":"4"}},{"id":2519527,"issuer":{"id":133686,"kind":"organization","name":"Kadmon Holdings, Inc.","symbol":"KDMN"},"owners":[{"id":28053,"kind":"person","name":"Waksal Harlan","position":1,"cik":"0001449008","reported_name":"Waksal Harlan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Stock Appreciation Right","published_at":"2021-11-09T17:42:11.000Z","date":"2021-11-09","kind":"disposition_to_issuer","acquired":true,"shares":655000,"price":5.86,"value":3838300.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the payment per share of Common Stock received in exchange for the cancellation of each Option, SAR and EAR."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"In connection with the Merger, all unvested stock options (\"Options\"), stock appreciation rights (\"SARs\") and equity appreciation rights (\"EARs\") were accelerated to full vesting and cancelled in exchange for a payment equal to $9.50 with respect to each share of Common Stock subject to such Option, SAR and EAR award."}],"balance_after":0,"derivative":{"exercise_price":3.64,"expiration_date":"2027-12-08","underlying":"Common Stock, par value $0.001","underlying_shares":655000},"source":{"system":"sec-edgar","filing":"0001104659-21-136412","document":"tm2131118-11_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1449008/000110465921136412/tm2131118-11_4seq1.xml","form_type":"4"}},{"id":2519526,"issuer":{"id":133686,"kind":"organization","name":"Kadmon Holdings, Inc.","symbol":"KDMN"},"owners":[{"id":28053,"kind":"person","name":"Waksal Harlan","position":1,"cik":"0001449008","reported_name":"Waksal Harlan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2021-11-09T17:42:11.000Z","date":"2021-11-09","kind":"disposition_to_issuer","acquired":false,"shares":177945,"price":9.5,"value":1690477.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Disposed pursuant to the acquisition by Sanofi of the entire issued share capital of Issuer on November 9, 2021 by means of a plan of merger (the \"Merger\")."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-21-136412","document":"tm2131118-11_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1449008/000110465921136412/tm2131118-11_4seq1.xml","form_type":"4"}},{"id":2710233,"issuer":{"id":133686,"kind":"organization","name":"Kadmon Holdings, Inc.","symbol":"KDMN"},"owners":[{"id":28053,"kind":"person","name":"Waksal Harlan","position":1,"cik":"0001449008","reported_name":"Waksal Harlan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2021-05-17T16:05:30.000Z","date":"2021-05-13","kind":"grant","acquired":true,"shares":25000,"price":3.5591,"value":88977.5,"ownership":{"direct":true},"balance_after":177945,"source":{"system":"sec-edgar","filing":"0001593968-21-001330","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1449008/000159396821001330/primary_01.xml","form_type":"4"}},{"id":2755665,"issuer":{"id":133686,"kind":"organization","name":"Kadmon Holdings, Inc.","symbol":"KDMN"},"owners":[{"id":28053,"kind":"person","name":"Waksal Harlan","position":1,"cik":"0001449008","reported_name":"Waksal Harlan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Performance Stock Option (right to buy)","published_at":"2021-04-06T16:25:37.000Z","date":"2021-04-03","kind":"grant","acquired":true,"shares":327498,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On April 3, 2018, the reporting person was granted performance based stock options to purchase an aggregate of 982,500 shares of Kadmon Holdings, Inc. common stock (the \"Performance Options\"), which may be earned based on the achievement of three separate performance goals related to the Company's operating and research and development activities. Any Performance Options earned will generally vest in three equal installments on specified vesting dates between the date of achievement of the performance goals and the third anniversary of the grant date based on continued employment. The compensation committee of the board of directors of the Company has determined the first, second and third performance goals have been met, and 327,498 Performance Options vested on April 3, 2021, pursuant to the aforementioned vesting schedule."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Only represents derivative securities of this class."}],"balance_after":982500,"derivative":{"exercise_price":4.06,"exercise_date":"2021-04-03","expiration_date":"2028-04-03","underlying":"Common Stock, par value $0.001","underlying_shares":327498},"source":{"system":"sec-edgar","filing":"0001593968-21-001092","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1449008/000159396821001092/primary_01.xml","form_type":"4"}},{"id":2909567,"issuer":{"id":133686,"kind":"organization","name":"Kadmon Holdings, Inc.","symbol":"KDMN"},"owners":[{"id":28053,"kind":"person","name":"Waksal Harlan","position":1,"cik":"0001449008","reported_name":"Waksal Harlan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Stock Option (right to buy)","published_at":"2021-01-12T16:27:40.000Z","date":"2021-01-08","kind":"grant","acquired":true,"shares":2000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in three equal annual installments over 3 years from January 8, 2021, the date of grant."}],"balance_after":2000000,"derivative":{"exercise_price":3.96,"expiration_date":"2031-01-08","underlying":"Common stock, par value $0.001","underlying_shares":2000000},"source":{"system":"sec-edgar","filing":"0001593968-21-000120","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1449008/000159396821000120/primary_01.xml","form_type":"4"}},{"id":3034343,"issuer":{"id":133686,"kind":"organization","name":"Kadmon Holdings, Inc.","symbol":"KDMN"},"owners":[{"id":28053,"kind":"person","name":"Waksal Harlan","position":1,"cik":"0001449008","reported_name":"Waksal Harlan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Performance Stock Option (right to buy)","published_at":"2020-09-10T17:02:27.000Z","date":"2020-09-10","kind":"grant","acquired":true,"shares":109167,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On April 3, 2018, the reporting person was granted performance based stock options to purchase an aggregate of 982,500 shares of Kadmon Holdings, Inc. common stock (the \"Performance Options\"), which may be earned based on the achievement of three separate performance goals related to the Company's operating and research and development activities. Any Performance Options earned will generally vest in three equal installments on specified vesting dates between the date of achievement of the performance goals and the third anniversary of the grant date based on continued employment. The compensation committee of the board of directors of the Company has determined the first, second and third performance goals have been met, and 109,167 Performance Options vested on September 10, 2020, pursuant to the aforementioned vesting schedule."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Only represents derivative securities of this class."}],"balance_after":655002,"derivative":{"exercise_price":4.06,"exercise_date":"2020-09-10","expiration_date":"2028-04-03","underlying":"Common Stock, par value $0.001","underlying_shares":109167},"source":{"system":"sec-edgar","filing":"0001593968-20-001855","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1449008/000159396820001855/primary_01.xml","form_type":"4"}},{"id":3208763,"issuer":{"id":133686,"kind":"organization","name":"Kadmon Holdings, Inc.","symbol":"KDMN"},"owners":[{"id":28053,"kind":"person","name":"Waksal Harlan","position":1,"cik":"0001449008","reported_name":"Waksal Harlan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock, par value $0.001","published_at":"2020-03-16T08:37:43.000Z","date":"2020-03-13","kind":"purchase","acquired":true,"shares":16000,"price":2.9257,"value":46811.2,"ownership":{"direct":true},"balance_after":152945,"source":{"system":"sec-edgar","filing":"0001593968-20-000776","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1449008/000159396820000776/primary_01.xml","form_type":"4"}},{"id":3215654,"issuer":{"id":133686,"kind":"organization","name":"Kadmon Holdings, Inc.","symbol":"KDMN"},"owners":[{"id":28053,"kind":"person","name":"Waksal Harlan","position":1,"cik":"0001449008","reported_name":"Waksal Harlan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock, par value $0.001","published_at":"2020-03-11T16:22:56.000Z","date":"2020-03-11","kind":"purchase","acquired":true,"shares":12600,"price":3.9571,"value":49859.46,"ownership":{"direct":true},"balance_after":136945,"source":{"system":"sec-edgar","filing":"0001593968-20-000728","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1449008/000159396820000728/primary_01.xml","form_type":"4"}},{"id":3215653,"issuer":{"id":133686,"kind":"organization","name":"Kadmon Holdings, Inc.","symbol":"KDMN"},"owners":[{"id":28053,"kind":"person","name":"Waksal Harlan","position":1,"cik":"0001449008","reported_name":"Waksal Harlan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock, par value $0.001","published_at":"2020-03-11T16:22:56.000Z","date":"2019-03-29","kind":"grant","acquired":true,"shares":7716,"price":2.25,"value":17361.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"The reporting person is voluntarily reporting the acquisition of shares of the issuer's common stock pursuant to the Kadmon Holdings, Inc Amended and Restated 2016 Employee Stock Purchase Plan (\"ESPP\"), for the ESPP purchase period of October 1, 2018 through March 31, 2019. This transaction is also exempt under Rule 16b-3(c)."},{"field":"date","element":"transactionDate","label":"F5","text":"The reporting person is voluntarily reporting this transaction on March 11, 2020, but the actual transaction took place on March 29, 2019, the last trading day of the option period under the ESPP."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing stock price on March 29, 2019, the last trading day of the option period."}],"balance_after":124345,"source":{"system":"sec-edgar","filing":"0001593968-20-000728","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1449008/000159396820000728/primary_01.xml","form_type":"4"}},{"id":3215652,"issuer":{"id":133686,"kind":"organization","name":"Kadmon Holdings, Inc.","symbol":"KDMN"},"owners":[{"id":28053,"kind":"person","name":"Waksal Harlan","position":1,"cik":"0001449008","reported_name":"Waksal Harlan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock, par value $0.001","published_at":"2020-03-11T16:22:56.000Z","date":"2018-09-28","kind":"grant","acquired":true,"shares":5882,"price":2.84,"value":16704.88,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of shares of the issuer's common stock pursuant to the Kadmon Holdings, Inc Amended and Restated 2016 Employee Stock Purchase Plan (\"ESPP\"), for the ESPP purchase period of April 1, 2018 through September 30, 2018. This transaction is also exempt under Rule 16b-3(c)."},{"field":"date","element":"transactionDate","label":"F2","text":"The reporting person is voluntarily reporting this transaction on March 11, 2020, but the actual transaction took place on September 28, 2018, the last trading day of the option period under the ESPP."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing stock price on September 28, 2018, the last trading day of the option period."}],"balance_after":116629,"source":{"system":"sec-edgar","filing":"0001593968-20-000728","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1449008/000159396820000728/primary_01.xml","form_type":"4"}},{"id":3365837,"issuer":{"id":133686,"kind":"organization","name":"Kadmon Holdings, Inc.","symbol":"KDMN"},"owners":[{"id":28053,"kind":"person","name":"Waksal Harlan","position":1,"cik":"0001449008","reported_name":"Waksal Harlan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Stock Option (right to buy)","published_at":"2019-11-19T18:16:16.000Z","date":"2019-11-19","kind":"grant","acquired":true,"shares":1350000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"This Amended Form 4 is being filed to correct an inaccuracy with respect to the exercise price of the stock options reported in Table II of the Form 4 filed on November 19, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable in three equal annual installments over 3 years from November 19, 2019, the date of grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Only represents derivative securities of this class."}],"balance_after":1350000,"derivative":{"exercise_price":4.15,"expiration_date":"2029-11-19","underlying":"Common stock, par value $0.001","underlying_shares":1350000},"source":{"system":"sec-edgar","filing":"0001593968-19-002180","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1449008/000159396819002180/primary_01.xml","form_type":"4/A","original_submission_date":"2019-11-19"}},{"id":3365836,"issuer":{"id":133686,"kind":"organization","name":"Kadmon Holdings, Inc.","symbol":"KDMN"},"owners":[{"id":28053,"kind":"person","name":"Waksal Harlan","position":1,"cik":"0001449008","reported_name":"Waksal Harlan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Stock Option (right to buy)","published_at":"2019-11-19T16:21:54.000Z","date":"2019-11-19","kind":"grant","acquired":true,"shares":1350000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in three equal annual installments over 3 years from November 19, 2019, the date of grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Only represents derivative securities of this class."}],"balance_after":1350000,"derivative":{"exercise_price":4.14,"expiration_date":"2029-11-19","underlying":"Common stock, par value $0.001","underlying_shares":1350000},"source":{"system":"sec-edgar","filing":"0001593968-19-002176","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1449008/000159396819002176/primary_01.xml","form_type":"4"}},{"id":3388678,"issuer":{"id":133686,"kind":"organization","name":"Kadmon Holdings, Inc.","symbol":"KDMN"},"owners":[{"id":28053,"kind":"person","name":"Waksal Harlan","position":1,"cik":"0001449008","reported_name":"Waksal Harlan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Performance Stock Option (right to buy)","published_at":"2019-10-24T16:42:30.000Z","date":"2019-10-24","kind":"grant","acquired":true,"shares":109167,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On April 3, 2018, the reporting person was granted performance based stock options to purchase an aggregate of 982,500 shares of Kadmon Holdings, Inc. common stock (the \"Performance Options\"), which may be earned based on the achievement of three separate performance goals related to the Company's operating and research and development activities. Any Performance Options earned will generally vest in three equal installments on specified vesting dates between the date of achievement of the performance goals and the third anniversary of the grant date based on continued employment. The compensation committee of the board of directors of the Company has determined the first, second and third performance goals have been met, and 109,167 Performance Options vested on October 24, 2019, pursuant to the aforementioned vesting schedule."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Only represents derivative securities of this class."}],"balance_after":545835,"derivative":{"exercise_price":4.06,"exercise_date":"2019-10-24","expiration_date":"2028-04-03","underlying":"Common Stock, par value $0.001","underlying_shares":109167},"source":{"system":"sec-edgar","filing":"0001593968-19-002016","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1449008/000159396819002016/primary_01.xml","form_type":"4"}},{"id":3418499,"issuer":{"id":133686,"kind":"organization","name":"Kadmon Holdings, Inc.","symbol":"KDMN"},"owners":[{"id":28053,"kind":"person","name":"Waksal Harlan","position":1,"cik":"0001449008","reported_name":"Waksal Harlan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Performance Stock Option (right to buy)","published_at":"2019-09-10T16:15:53.000Z","date":"2019-09-10","kind":"grant","acquired":true,"shares":109167,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On April 3, 2018, the reporting person was granted performance based stock options to purchase an aggregate of 982,500 shares of Kadmon Holdings, Inc. common stock (the \"Performance Options\"), which may be earned based on the achievement of three separate performance goals related to the Company's operating and research and development activities. Any Performance Options earned will generally vest in three equal installments on specified vesting dates between the date of achievement of the performance goals and the third anniversary of the grant date based on continued employment. The compensation committee of the board of directors of the Company has determined the first, second and third performance goals have been met, and 109,167 Performance Options vested on September 10, 2019."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Only represents derivative securities of this class."}],"balance_after":436668,"derivative":{"exercise_price":4.06,"exercise_date":"2019-09-10","expiration_date":"2028-04-03","underlying":"Common Stock, par value $0.001","underlying_shares":109167},"source":{"system":"sec-edgar","filing":"0001593968-19-001871","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1449008/000159396819001871/primary_01.xml","form_type":"4"}},{"id":3489494,"issuer":{"id":133686,"kind":"organization","name":"Kadmon Holdings, Inc.","symbol":"KDMN"},"owners":[{"id":28053,"kind":"person","name":"Waksal Harlan","position":1,"cik":"0001449008","reported_name":"Waksal Harlan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Performance Stock Option (right to buy)","published_at":"2019-06-14T16:19:30.000Z","date":"2019-06-14","kind":"grant","acquired":true,"shares":109167,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On April 3, 2018, the reporting person was granted performance based stock options to purchase an aggregate of 982,500 shares of Kadmon Holdings, Inc. common stock (the \"Performance Options\"), which may be earned based on the achievement of three separate performance goals related to the Company's operating and research and development activities. Any Performance Options earned will generally vest in three equal installments on specified vesting dates between the date of achievement of the performance goals and the third anniversary of the grant date based on continued employment. The compensation committee of the board of directors of the Company has determined the first and second performance goals have been met, and 109,167 Performance Options vested on June 14, 2019."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Only represents derivative securities of this class."}],"balance_after":327501,"derivative":{"exercise_price":4.06,"exercise_date":"2019-06-14","expiration_date":"2028-04-03","underlying":"Common Stock, par value $0.001","underlying_shares":109167},"source":{"system":"sec-edgar","filing":"0001593968-19-001433","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1449008/000159396819001433/primary_01.xml","form_type":"4"}},{"id":3561314,"issuer":{"id":133686,"kind":"organization","name":"Kadmon Holdings, Inc.","symbol":"KDMN"},"owners":[{"id":28053,"kind":"person","name":"Waksal Harlan","position":1,"cik":"0001449008","reported_name":"Waksal Harlan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Performance Stock Option (right to buy)","published_at":"2019-04-05T16:19:14.000Z","date":"2019-04-03","kind":"grant","acquired":true,"shares":218334,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On April 3, 2018, the reporting person was granted performance based stock options to purchase an aggregate of 982,500 shares of Kadmon Holdings, Inc. common stock (the \"Performance Options\"), which may be earned based on the achievement of three separate performance milestones related to the Company's operating and research and development activities. Any Performance Options earned will generally vest in three equal installments on specified vesting dates between the date of achievement and the third anniversary of the grant date based on continued employment. The compensation committee of the board of directors of the Company has determined the first and second Performance Goals have been achieved, and 218,334 Performance Options vested on April 3, 2019."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Only represents derivative securities of this class."}],"balance_after":218334,"derivative":{"exercise_price":4.06,"exercise_date":"2019-04-03","expiration_date":"2028-04-03","underlying":"Commom Stock, par value $0.001","underlying_shares":218334},"source":{"system":"sec-edgar","filing":"0001593968-19-000935","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1449008/000159396819000935/primary_01.xml","form_type":"4"}},{"id":4134717,"issuer":{"id":133686,"kind":"organization","name":"Kadmon Holdings, Inc.","symbol":"KDMN"},"owners":[{"id":28053,"kind":"person","name":"Waksal Harlan","position":1,"cik":"0001449008","reported_name":"Waksal Harlan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Stock Appreciation Right","published_at":"2017-12-12T16:12:32.000Z","date":"2017-12-08","kind":"grant","acquired":true,"shares":655000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock appreciation right vests and becomes exercisable in three equal annual installments over 3 years from December 8, 2017, the date of grant."}],"balance_after":655000,"derivative":{"exercise_price":3.64,"expiration_date":"2027-12-08","underlying":"Common Stock, par value $0.001","underlying_shares":655000},"source":{"system":"sec-edgar","filing":"0001593968-17-001355","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1449008/000159396817001355/primary_01.xml","form_type":"4"}},{"id":4237769,"issuer":{"id":133686,"kind":"organization","name":"Kadmon Holdings, Inc.","symbol":"KDMN"},"owners":[{"id":28053,"kind":"person","name":"Waksal Harlan","position":1,"cik":"0001449008","reported_name":"Waksal Harlan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock, par value $0.001","published_at":"2017-08-10T16:42:03.000Z","date":"2017-08-10","kind":"purchase","acquired":true,"shares":5000,"price":2.2665,"value":11332.5,"ownership":{"direct":true},"balance_after":110747,"source":{"system":"sec-edgar","filing":"0001593968-17-000976","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1449008/000159396817000976/primary_01.xml","form_type":"4"}},{"id":4240043,"issuer":{"id":133686,"kind":"organization","name":"Kadmon Holdings, Inc.","symbol":"KDMN"},"owners":[{"id":28053,"kind":"person","name":"Waksal Harlan","position":1,"cik":"0001449008","reported_name":"Waksal Harlan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock, par value $0.001","published_at":"2017-08-08T21:45:59.000Z","date":"2017-08-08","kind":"purchase","acquired":true,"shares":3707,"price":2.3379,"value":8666.5953,"ownership":{"direct":true},"balance_after":105747,"source":{"system":"sec-edgar","filing":"0001593968-17-000971","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1449008/000159396817000971/primary_01.xml","form_type":"4"}},{"id":4552963,"issuer":{"id":133686,"kind":"organization","name":"Kadmon Holdings, Inc.","symbol":"KDMN"},"owners":[{"id":28053,"kind":"person","name":"Waksal Harlan","position":1,"cik":"0001449008","reported_name":"Waksal Harlan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock, par value $0.001","published_at":"2016-11-16T16:32:28.000Z","date":"2016-11-16","kind":"purchase","acquired":true,"shares":2000,"price":6.3666,"value":12733.2,"ownership":{"direct":true},"balance_after":102040,"source":{"system":"sec-edgar","filing":"0001593968-16-001209","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1449008/000159396816001209/primary_01.xml","form_type":"4"}},{"id":4557780,"issuer":{"id":133686,"kind":"organization","name":"Kadmon Holdings, Inc.","symbol":"KDMN"},"owners":[{"id":28053,"kind":"person","name":"Waksal Harlan","position":1,"cik":"0001449008","reported_name":"Waksal Harlan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock, par value $0.001","published_at":"2016-11-14T20:06:23.000Z","date":"2016-11-14","kind":"purchase","acquired":true,"shares":2000,"price":6.79,"value":13580.0,"ownership":{"direct":true},"balance_after":100040,"source":{"system":"sec-edgar","filing":"0001593968-16-001195","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1449008/000159396816001195/primary_01.xml","form_type":"4"}}]}